NFKB1 and type 2 diabetes mellitus: Clinical studies have shown that when inflammation in T2DM patients is suppressed by a high dose of aspirin or salsalate, the glycemic control of the patients improves, along with concomitant inhibition of NF-κB activity (Lee and Lee, 2014).